These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 26333890)

  • 1. The effect of 12-wk ω-3 fatty acid supplementation on in vivo thalamus glutathione concentration in patients "at risk" for major depression.
    Duffy SL; Lagopoulos J; Cockayne N; Lewis SJ; Hickie IB; Hermens DF; Naismith SL
    Nutrition; 2015 Oct; 31(10):1247-54. PubMed ID: 26333890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative stress and depressive symptoms in older adults: A magnetic resonance spectroscopy study.
    Duffy SL; Lagopoulos J; Cockayne N; Hermens DF; Hickie IB; Naismith SL
    J Affect Disord; 2015 Jul; 180():29-35. PubMed ID: 25881278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Omega-3 polyunsaturated fatty acid supplementation and white matter changes in major depression.
    Chhetry BT; Hezghia A; Miller JM; Lee S; Rubin-Falcone H; Cooper TB; Oquendo MA; Mann JJ; Sublette ME
    J Psychiatr Res; 2016 Apr; 75():65-74. PubMed ID: 26802812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of supplementation with omega-3 fatty acids on oxidative stress and inflammation in patients with Alzheimer's disease: the OmegAD study.
    Freund-Levi Y; Vedin I; Hjorth E; Basun H; Faxén Irving G; Schultzberg M; Eriksdotter M; Palmblad J; Vessby B; Wahlund LO; Cederholm T; Basu S
    J Alzheimers Dis; 2014; 42(3):823-31. PubMed ID: 24934544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transfer of omega-3 fatty acids across the blood-brain barrier after dietary supplementation with a docosahexaenoic acid-rich omega-3 fatty acid preparation in patients with Alzheimer's disease: the OmegAD study.
    Freund Levi Y; Vedin I; Cederholm T; Basun H; Faxén Irving G; Eriksdotter M; Hjorth E; Schultzberg M; Vessby B; Wahlund LO; Salem N; Palmblad J
    J Intern Med; 2014 Apr; 275(4):428-36. PubMed ID: 24410954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Omega-3 Fatty Acid Supplementation on Memory Functions in Healthy Older Adults.
    Külzow N; Witte AV; Kerti L; Grittner U; Schuchardt JP; Hahn A; Flöel A
    J Alzheimers Dis; 2016; 51(3):713-25. PubMed ID: 26890759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Anterior Cingulate Glutathione with Sleep Apnea in Older Adults At-Risk for Dementia.
    Duffy SL; Lagopoulos J; Terpening Z; Lewis SJ; Grunstein R; Mowszowski L; Cross N; Hermens DF; Hickie IB; Naismith SL
    Sleep; 2016 Apr; 39(4):899-906. PubMed ID: 26856906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Long-term Supplementation With Marine Omega-3 Fatty Acids vs Placebo on Risk of Depression or Clinically Relevant Depressive Symptoms and on Change in Mood Scores: A Randomized Clinical Trial.
    Okereke OI; Vyas CM; Mischoulon D; Chang G; Cook NR; Weinberg A; Bubes V; Copeland T; Friedenberg G; Lee IM; Buring JE; Reynolds CF; Manson JE
    JAMA; 2021 Dec; 326(23):2385-2394. PubMed ID: 34932079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depression in Parkinson's disease: a double-blind, randomized, placebo-controlled pilot study of omega-3 fatty-acid supplementation.
    da Silva TM; Munhoz RP; Alvarez C; Naliwaiko K; Kiss A; Andreatini R; Ferraz AC
    J Affect Disord; 2008 Dec; 111(2-3):351-9. PubMed ID: 18485485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of n-3 fatty acids, EPA v. DHA, on depressive symptoms, quality of life, memory and executive function in older adults with mild cognitive impairment: a 6-month randomised controlled trial.
    Sinn N; Milte CM; Street SJ; Buckley JD; Coates AM; Petkov J; Howe PR
    Br J Nutr; 2012 Jun; 107(11):1682-93. PubMed ID: 21929835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized controlled trial to prevent post-operative atrial fibrillation by antioxidant reinforcement.
    Rodrigo R; Korantzopoulos P; Cereceda M; Asenjo R; Zamorano J; Villalabeitia E; Baeza C; Aguayo R; Castillo R; Carrasco R; Gormaz JG
    J Am Coll Cardiol; 2013 Oct; 62(16):1457-65. PubMed ID: 23916928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial.
    Freund-Levi Y; Eriksdotter-Jönhagen M; Cederholm T; Basun H; Faxén-Irving G; Garlind A; Vedin I; Vessby B; Wahlund LO; Palmblad J
    Arch Neurol; 2006 Oct; 63(10):1402-8. PubMed ID: 17030655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dietary intake in population-based adolescents: support for a relationship between eating disorder symptoms, low fatty acid intake and depressive symptoms.
    Allen KL; Mori TA; Beilin L; Byrne SM; Hickling S; Oddy WH
    J Hum Nutr Diet; 2013 Oct; 26(5):459-69. PubMed ID: 23216519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of randomized supplementation with high dose olive, flax or fish oil on serum phospholipid fatty acid levels in adults with attention deficit hyperactivity disorder.
    Young GS; Conquer JA; Thomas R
    Reprod Nutr Dev; 2005; 45(5):549-58. PubMed ID: 16188207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of omega-3 fatty acids on the modification of erythrocyte membrane fatty acid content including oleic acid in peritoneal dialysis patients.
    An WS; Lee SM; Son YK; Kim SE; Kim KH; Han JY; Bae HR; Park Y
    Prostaglandins Leukot Essent Fatty Acids; 2012; 86(1-2):29-34. PubMed ID: 22071008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel, multi-ingredient supplement to manage elevated blood lipids in patients with no evidence of cardiovascular disease: a pilot study.
    Hobbs T; Caso R; McMahon D; Nymark M
    Altern Ther Health Med; 2014; 20(5):18-23. PubMed ID: 25141367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of n-3 supplementation on hyperactivity, oxidative stress and inflammatory mediators in children with attention-deficit-hyperactivity disorder.
    Hariri M; Djazayery A; Djalali M; Saedisomeolia A; Rahimi A; Abdolahian E
    Malays J Nutr; 2012 Dec; 18(3):329-35. PubMed ID: 24568073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Docosahexaenoic and eicosapentaenoic acid supplementation does not exacerbate oxidative stress or intravascular haemolysis in homozygous sickle cell patients.
    Daak AA; Ghebremeskel K; Mariniello K; Attallah B; Clough P; Elbashir MI
    Prostaglandins Leukot Essent Fatty Acids; 2013 Oct; 89(5):305-11. PubMed ID: 24095588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Omega-3 supplementation can restore glutathione levels and prevent oxidative damage caused by prenatal ethanol exposure.
    Patten AR; Brocardo PS; Christie BR
    J Nutr Biochem; 2013 May; 24(5):760-9. PubMed ID: 22841392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Omega-3 fatty acid supplementation decreases liver fat content in polycystic ovary syndrome: a randomized controlled trial employing proton magnetic resonance spectroscopy.
    Cussons AJ; Watts GF; Mori TA; Stuckey BG
    J Clin Endocrinol Metab; 2009 Oct; 94(10):3842-8. PubMed ID: 19622617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.